El Hospital Clínico de la Universidad de Chile José Joaquín Aguirre, popularmente conocido como «Jota Aguirre» o «Jota Jota Aguirre», es un hospital universitario ubicado en la comuna de Independencia, en el sector norte de la ciudad de Santiago de Chile.

During the past decade, Hospital Clínico Universidad de Chile conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 9 clinical trials were completed, i.e. on average, 19.1% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 7 clinical trials were completed. i.e. 29.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clínico Universidad de Chile" #1 sponsor was "University of Chile" with 34 trials, followed by "Pfizer" with 6 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Genfit" with 2 trials sponsored and "King's College Hospital NHS Trust" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clínico Universidad de Chile" #1 collaborator was "Comisión Nacional de Investigación Científica y Tecnológica" with 3 trials as a collaborator, "Fondo Nacional de Desarrollo Científico y Tecnológico, Chile" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "ClinIntel" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clínico Universidad de Chile" are "Pain, Postoperative" (7 trials), "Analgesia" (4 trials), "Surgical Procedure, Unspecified" (4 trials), "Diaphragmatic Paralysis" (3 trials) and "Pain, Acute" (3 trials). Many other conditions were trialed in "Hospital Clínico Universidad de Chile" in a lesser frequency.

Most popular intervention types in "Hospital Clínico Universidad de Chile" are "Drug" (27 trials), "Procedure" (13 trials), "Device" (9 trials), "Other" (7 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Abrocitinib 200 mg" (2 trials), "Cisplatin" (2 trials), "Dexamethasone" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clínico Universidad de Chile" are 55 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Clínico Universidad de Chile". 2 are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Hospital Clínico Universidad de Chile, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clínico Universidad de Chile, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 26 trials that are defined as “Not Applicable".